Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...

Some 40 knee arthritis sufferers have undergone the treatment, called genicular arterial embolisation, as part of a trial by the Royal Berkshire NHS Foundation Trust and University of Reading.

A groundbreaking study shows that the weight-loss drug semaglutide can significantly reduce knee pain from obesity-related ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...

NEW DELHI: Delay in proper knee treatment, timely detection and ignoring knee arthritis symptoms can worsen the condition of knees and additionally damage the spine affecting the quality of life, ...